L3VLUP
ProSign in

MSA · JNJ in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

MSAJNJ
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • MSA
  • JNJ
0204060202120222023202420252026
Holders and value by quarter
QuarterMSAJNJ
Q3 20204 holders, $493m30 holders, $26.2bn
Q4 20203 holders, $481m32 holders, $26.6bn
Q1 20213 holders, $246m31 holders, $25.3bn
Q2 20213 holders, $265m37 holders, $25.6bn
Q3 20213 holders, $229m40 holders, $24.1bn
Q4 20211 holders, $228m33 holders, $25.2bn
Q1 20221 holders, $197m35 holders, $28.2bn
Q2 20221 holders, $2.8m33 holders, $26.9bn
Q3 20221 holders, $1.3m36 holders, $25.4bn
Q4 20222 holders, $16m35 holders, $27.6bn
Q1 20232 holders, $30m42 holders, $24.5bn
Q2 20232 holders, $46m38 holders, $25.0bn
Q3 20231 holders, $35m37 holders, $18.9bn
Q4 20234 holders, $49m31 holders, $19.0bn
Q1 20247 holders, $294m32 holders, $19.7bn
Q2 20244 holders, $274m35 holders, $20.4bn
Q3 20244 holders, $248m28 holders, $22.3bn
Q4 20245 holders, $277m37 holders, $20.4bn
Q1 20256 holders, $247m32 holders, $20.5bn
Q2 20256 holders, $444m31 holders, $18.4bn
Q3 20255 holders, $385m32 holders, $23.7bn
Q4 20256 holders, $324m29 holders, $27.8bn
Q1 20267 holders, $354m34 holders, $35.6bn
Q2 20264 holders, $367m33 holders, $39.1bn
MSA

Msa Safety Inc

Holders
4
Reported value
$49m
Buyers
3
Sellers
1

Breadth +2 among 93 comparable managers.

Medical devices and instrumentsHealthcare: biopharma and medtech · L3VLUPSurgical, medical and electromedical devices
JNJ

Johnson & Johnson

Holders
31
Reported value
$19.0bn
Buyers
16
Sellers
16

Breadth 0 among 93 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q4 2023

Among the 33 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only MSA (2)

Baillie Gifford & Co, Capital World Investors

Only JNJ (29)

Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, Bridgewater Associates LP, Capital Research Global Investors, D. E. Shaw & Co., Dodge & Cox, ExodusPoint Capital Management LP, Fidelity (FMR LLC), GAMCO Investors Inc, Hudson Bay Capital Management LP, Invesco Ltd, Jane Street Group LLC, Janus Henderson Group Ltd, Man Group PLC, Markel Group Inc, MFS Investment Management, Neuberger Berman Group LLC, Renaissance Technologies LLC, Squarepoint Ops LLC, Susquehanna International Group LLP, T. Rowe Price Associates Inc, Tudor Investment Corp, Two Sigma Advisers LP, Two Sigma Investments LP, and 4 more

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →